Market Overview:
The global prenatal and newborn genetic testing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of chromosomal abnormalities, rising demand for non-invasive tests, and technological advancements in prenatal and newborn genetic testing. Based on type, the global prenatal and newborn genetic testing market is segmented into array-comparative genetic hybridization (aCGH), fluorescence in situ hybridization (FISH), and polymerase chain reaction (PCR). The aCGH segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to its ability to detect copy number variations with high accuracy. Based on application, the global prenatal and newborn genetic testing market is segmented into hospitals, diagnostic organizations, research laboratories/universities, other clinical settings such as clinics or private practices, commercial laboratories/IVD companies; pharmacogenomics laboratories; paternity test centers; forensic labs; agricultural biotechnology companies etc., pregnant women counseling centers & preconception care clinics etc., In terms of geography, North America dominates the global prenatal and newborn Genetic Testing Market followed by Europe due To factors such as increasing prevalence of chromosomal abnormalities,, growing demand for non-invasive tests,, technological advancements in this field And rising awareness about benefits Of Prenatal And Newborn Genetic Testing among healthcare professionals And pregnant women are driving this regional Market .
Product Definition:
Prenatal and Newborn Genetic Testing is a medical procedure that screens for any possible genetic abnormalities in the fetus or newborn. The purpose of this testing is to identify any potential health risks that may occur during pregnancy or after birth.
Array-Comparative Genetic Hybridization(aCGH):
array-comparative genetic hybridization (aCGH) is a molecular technique that allows the in-depth study of normal and pathological cellular processes. It works by detecting and analyzing DNA sequences. The technology has been around for more than two decades, but only within the past decade or so has it begun to be applied to prenatal testing as well as newborn screening programs.
Fluorescence In-Situ Hybridization(FISH):
Fluorescence in-situ hybridization(FISH) is a technique used for visualizing and mapping genetic structures such as DNA sequences, genes, and other structural elements of the genome. It is an extension to traditional in-vitro hybridization techniques. The method allows simultaneous detection of multiple targets on a single nucleic acid probe along with its localization within the genome of interest.
Application Insights:
The other application segment includes research institutes and diagnostic laboratories. The other segment held the largest market share in 2017, as a result of increasing adoption prenatal and newborn genetic testing for various applications such as carrier screening, amniocentesis, Down syndrome testing among others.
Carrier screening is one of the significant applications that are anticipated to drive the global prenatal and newborn genetic testing market over the forecast period due to its high accuracy rate compared to traditional family history methods. Moreover, it reduces risk by providing information about possible genealogical ties with non-family members which include extended relatives (aunts/uncles), first cousins once removed (cousins)and second cousins once removed (nieces/nephews).
Amniocentesis is another significant application that is used for analyzing DNA present in amniotic fluid which can be transmitted from mother to fetus through placenta during pregnancy.
Regional Analysis:
North America dominated the global prenatal and newborn genetic testing market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of technologically advanced products/services, and government support for research & development activities. Moreover, increasing incidence of congenital disorders is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare facilities in rural as well as urban areas coupled with rising disposable income among people affected with various chronic diseases such as diabetes or hypertension during pregnancy. These factors are contributing toward increased demand for diagnostic services related prenatal screening throughout this region which will further boost revenue generation prospects over next eight years or so to come.
Major players operating in this industry include but are not limited to; Advanced Cell Diagnostics (ACT), BioDirection (BID), CELGENE CORP.
Growth Factors:
- Increasing demand for prenatal and newborn genetic testing due to the increasing incidence of genetic disorders.
- Rising awareness about the benefits of prenatal and newborn genetic testing among pregnant women and parents-to-be.
- Growing number of private clinics offering prenatal and newborn genetic testing services.
- Availability of affordable prenatal and newborn genetic testing services through online platforms.
- Proliferation of new technologies in prenatal and newborn genetics that are helping to improve accuracy levels of tests
Scope Of The Report
Report Attributes
Report Details
Report Title
Prenatal and Newborn Genetic Testing Market Research Report
By Type
Array-Comparative Genetic Hybridization(aCGH), Fluorescence In-Situ Hybridization(FISH), Polymerase Chain Reaction(PCR)
By Application
Hospitals, Diagnostic Organization, Other
By Companies
Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics, Quest Diagnostic, Bio-Rad, AutoGenomics, Abbott, Cepheid, EKF Diagnostics, Natera, Agilent Technologies, Illumina, Ariosa Diagnostics, Sequenom
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Prenatal and Newborn Genetic Testing Market Report Segments:
The global Prenatal and Newborn Genetic Testing market is segmented on the basis of:
Types
Array-Comparative Genetic Hybridization(aCGH), Fluorescence In-Situ Hybridization(FISH), Polymerase Chain Reaction(PCR)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Organization, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostic
- Elitech Group
- Myriad Genetics
- Biocartis
- IntegraGen
- Perkin Elmer
- WaferGen Biosystem
- Interpace Diagnostics
- Quest Diagnostic
- Bio-Rad
- AutoGenomics
- Abbott
- Cepheid
- EKF Diagnostics
- Natera
- Agilent Technologies
- Illumina
- Ariosa Diagnostics
- Sequenom
Highlights of The Prenatal and Newborn Genetic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Array-Comparative Genetic Hybridization(aCGH)
- Fluorescence In-Situ Hybridization(FISH)
- Polymerase Chain Reaction(PCR)
- By Application:
- Hospitals
- Diagnostic Organization
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prenatal and Newborn Genetic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prenatal and newborn genetic testing is a process by which a doctor can determine the genetic makeup of an unborn baby. This information can be used to help make decisions about the baby's health and future.
Some of the key players operating in the prenatal and newborn genetic testing market are Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics, Quest Diagnostic, Bio-Rad, AutoGenomics, Abbott, Cepheid, EKF Diagnostics, Natera, Agilent Technologies, Illumina, Ariosa Diagnostics, Sequenom.
The prenatal and newborn genetic testing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prenatal and Newborn Genetic Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prenatal and Newborn Genetic Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prenatal and Newborn Genetic Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prenatal and Newborn Genetic Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prenatal and Newborn Genetic Testing Market Size & Forecast, 2018-2028
4.5.1 Prenatal and Newborn Genetic Testing Market Size and Y-o-Y Growth
4.5.2 Prenatal and Newborn Genetic Testing Market Absolute $ Opportunity
Chapter 5 Global Prenatal and Newborn Genetic Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Prenatal and Newborn Genetic Testing Market Size Forecast by Type
5.2.1 Array-Comparative Genetic Hybridization(aCGH)
5.2.2 Fluorescence In-Situ Hybridization(FISH)
5.2.3 Polymerase Chain Reaction(PCR)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Prenatal and Newborn Genetic Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Prenatal and Newborn Genetic Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Organization
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prenatal and Newborn Genetic Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prenatal and Newborn Genetic Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Prenatal and Newborn Genetic Testing Analysis and Forecast
9.1 Introduction
9.2 North America Prenatal and Newborn Genetic Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Prenatal and Newborn Genetic Testing Market Size Forecast by Type
9.6.1 Array-Comparative Genetic Hybridization(aCGH)
9.6.2 Fluorescence In-Situ Hybridization(FISH)
9.6.3 Polymerase Chain Reaction(PCR)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Prenatal and Newborn Genetic Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Organization
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Prenatal and Newborn Genetic Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Prenatal and Newborn Genetic Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Prenatal and Newborn Genetic Testing Market Size Forecast by Type
10.6.1 Array-Comparative Genetic Hybridization(aCGH)
10.6.2 Fluorescence In-Situ Hybridization(FISH)
10.6.3 Polymerase Chain Reaction(PCR)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Prenatal and Newborn Genetic Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Organization
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Prenatal and Newborn Genetic Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Prenatal and Newborn Genetic Testing Market Size Forecast by Type
11.6.1 Array-Comparative Genetic Hybridization(aCGH)
11.6.2 Fluorescence In-Situ Hybridization(FISH)
11.6.3 Polymerase Chain Reaction(PCR)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Prenatal and Newborn Genetic Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Organization
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Prenatal and Newborn Genetic Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Prenatal and Newborn Genetic Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Prenatal and Newborn Genetic Testing Market Size Forecast by Type
12.6.1 Array-Comparative Genetic Hybridization(aCGH)
12.6.2 Fluorescence In-Situ Hybridization(FISH)
12.6.3 Polymerase Chain Reaction(PCR)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Prenatal and Newborn Genetic Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Organization
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Prenatal and Newborn Genetic Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Prenatal and Newborn Genetic Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Prenatal and Newborn Genetic Testing Market Size Forecast by Type
13.6.1 Array-Comparative Genetic Hybridization(aCGH)
13.6.2 Fluorescence In-Situ Hybridization(FISH)
13.6.3 Polymerase Chain Reaction(PCR)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Prenatal and Newborn Genetic Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Organization
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prenatal and Newborn Genetic Testing Market: Competitive Dashboard
14.2 Global Prenatal and Newborn Genetic Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostic
14.3.2 Elitech Group
14.3.3 Myriad Genetics
14.3.4 Biocartis
14.3.5 IntegraGen
14.3.6 Perkin Elmer
14.3.7 WaferGen Biosystem
14.3.8 Interpace Diagnostics
14.3.9 Quest Diagnostic
14.3.10 Bio-Rad
14.3.11 AutoGenomics
14.3.12 Abbott
14.3.13 Cepheid
14.3.14 EKF Diagnostics
14.3.15 Natera
14.3.16 Agilent Technologies
14.3.17 Illumina
14.3.18 Ariosa Diagnostics
14.3.19 Sequenom
